Teva's CEO talks Q4 earnings and how he is implementing his 'pivot to growth' strategy - YouTube
If You Had Bought Teva Pharmaceutical Industries (NYSE:TEVA) Stock Three Years Ago, You'd Be Sitting On A 82% Loss, Today
Teva Pharmaceuticals Yahoo Finance Spain, SAVE 35% - mpgc.net
Teva Reports Second Quarter 2023 Financial Results
Teva Pharmaceutical Industries Ltd. (TEVA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Teva Pharmaceuticals Yahoo Finance Spain, SAVE 35% - mpgc.net
Yahoo Finance - Stock Market Live, Quotes, Business & Finance News
Teva stock pops on Q2 results, CEO sees 'significant' potential for trio of branded drugs - YouTube
Teva considers sale of its active ingredients unit: Bloomberg - YouTube
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024
Unveiling Teva Pharmaceutical Industries (TEVA)'s Value: Is It Really Priced Right? A ...
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote - YouTube
Teva Pharmaceuticals on X: "Teva CEO, Richard Francis, shared his perspective with @YahooFinance on our Q4 and full-year 2023 performance. Watch the interview here: https://t.co/mpW5LMoDEb $Teva #QuarterlyResults #Earnings https://t.co/kU3LpV7Ctl" / X
Teva Reports Growth in Fourth Quarter and Full Year 2023
Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
Teva Pharmaceutical upgraded to 'Buy' at UBS
Teva stock pops on Q2 results, CEO sees 'significant' potential for trio of branded drugs
Chief Accounting Officer Amir Weiss Sells 31,766 Shares of Teva Pharmaceutical Industries Ltd
TEVA Q4 Earnings and Revenues Surpass Estimates, Stock Up
Teva considers sale of its active ingredients unit: Bloomberg
Teva Pharmaceutical Industries Ltd (TEVA) Reports Solid Growth in 2023 Earnings
